Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8812230 | 0.98 | LMNA (0.39) | LMNATSHRSMN1; SMN2BLM | |
| SCHEMBL8812578 | 0.98 | LMNA (0.39) | LMNATSHRSMN1; SMN2BLM | |
| SCHEMBL6822541 | 0.96 | LMNA (0.37) | LMNATSHRSMN1; SMN2BLM | |
| SCHEMBL11762223 | 0.95 | LMNA (0.35) | LMNATSHRSMN1; SMN2ALDH1A1MAPK1 | |
| SCHEMBL1784618 | 0.90 | ALDH1A1 (0.33) | TSHRSMN1; SMN2ALDH1A1MAPK1TDP1 | |
| SCHEMBL11765919 | 0.86 | ALDH1A1 (0.35) | LMNATSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL1966551 | 0.85 | LMNA (0.41) | LMNAALDH1A1MAPK1TDP1BLM | |
| SCHEMBL11761561 | 0.85 | ALDH1A1 (0.34) | LMNATSHRSMN1; SMN2ALDH1A1TDP1 | |
| SCHEMBL11765070 | 0.85 | LMNA (0.31) | LMNATSHRSMN1; SMN2 | |
| SCHEMBL11766136 | 0.84 | TSHR (0.41) | LMNATSHRSMN1; SMN2ALDH1A1BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240407983-A1 | (R,E)-3,7-DIMETHYLNON-6-ENAL, ISOMERIC MIXTURES OF THE COMPOUND AND THE USE IN PERFUMERY | GIVAUDAN SA (CH) | 2024-12-12 | — | — | US | disclosed |
| EP-4412973-A1 | (R,E)-3,7-DIMETHYLNON-6-ENAL, ISOMERIC MIXTURES OF THE COMPOUND AND THE USE IN PERFUMERY | Givaudan SA (CH) | 2024-08-14 | — | — | EP | disclosed |
| CN-118055916-A | (R, E) -3, 7-dimethyl-non-6-enal, isomer mixture of the compound and application in perfume | 奇华顿股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| WO-2023057421-A1 | (R,E)-3,7-DIMETHYLNON-6-ENAL, ISOMERIC MIXTURES OF THE COMPOUND AND THE USE IN PERFUMERY | GIVAUDAN SA (CH) | 2023-04-13 | — | — | WO | disclosed |
| US-8632792-B2 | Cooling sensation agent composition and sensory stimulation agent composition | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2014-01-21 | — | — | US | disclosed |
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2011-05-19 | — | — | US | disclosed |
| WO-2009123355-A2 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2009-10-08 | — | — | WO | disclosed |
| US-4021461-A | INSECTICIDES | ZOECON CORPORATION (US) | 1977-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110117147-A1 | COOLING SENSATION AGENT COMPOSITION AND SENSORY STIMULATION AGENT COMPOSITION | TRPA1, HRH1, HRH2 | LMNA 1708/4885TSHR 2479/4885SMN1; SMN2 2144/4885 |
| US-20240407983-A1 | (R,E)-3,7-DIMETHYLNON-6-ENAL, ISOMERIC MIXTURES OF THE COMPOUND AND THE USE IN PERFUMERY | CYP2D6, G6PD, ECI1 | LMNA 1127/4885TSHR 4208/4885SMN1; SMN2 3115/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.